Clinical Trials Browser

Phase 2 × Leukemia × treosulfan × Clear all

NCT01062490 2010-02-04

Treosulfan Based Conditioning Myelodysplastic Syndrome (MDS)

Phase 2 Completed

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes